Exablate Blood-Brain Barrier Disruption With Carboplatin for the Treatment of rGBM
Clinical trial NCT04440358 · COMPLETED
Trial details
- NCT number
- NCT04440358
- Sponsor
- InSightec
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2023-11-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.